Marine‐derived n‐3 fatty acids therapy vs No marine‐derived n‐3 fatty acids therapy
Recurrent events: fatal or non‐fatal (same type of stroke, i.e. ischaemic or haemorrhagic) · stroke and/or TIA
It is very uncertain whether marine‐derived n‐3 fatty acids therapy changes recurrent events: fatal or non‐fatal (same type of stroke, i.e.… compared with no marine‐derived n‐3 fatty acids therapy (very low certainty).
1 finding from 1 review
- RR 0.41 [0.02, 8.84]1 study · 18 participantsVery low